▶ 調査レポート

敗血症診断の世界市場(~2026年)

• 英文タイトル:Global Sepsis Diagnostic Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。敗血症診断の世界市場(~2026年) / Global Sepsis Diagnostic Market Size, Status and Forecast 2020-2026 / MRC2-11QY04584資料のイメージです。• レポートコード:MRC2-11QY04584
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は敗血症診断のグローバル市場について調査・分析したレポートです。種類別(臨床検査、ポイントオブケア検査)市場規模、用途別(病院、病理学および参照研究所)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別敗血症診断の競争状況、市場シェア
・世界の敗血症診断市場:種類別市場規模 2015年-2020年(臨床検査、ポイントオブケア検査)
・世界の敗血症診断市場:種類別市場規模予測 2021年-2026年(臨床検査、ポイントオブケア検査)
・世界の敗血症診断市場:用途別市場規模 2015年-2020年(病院、病理学および参照研究所)
・世界の敗血症診断市場:用途別市場規模予測 2021年-2026年(病院、病理学および参照研究所)
・北米の敗血症診断市場分析:米国、カナダ
・ヨーロッパの敗血症診断市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの敗血症診断市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の敗血症診断市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの敗血症診断市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Bruker (US)、CytoSorbents (US)、EKF (US)、T2 Biosystems (US)、Luminex (US)、Thermo Fisher Scientific (US)、bioMerieux (France)、Danaher (US)、Becton, Dickinson and Company (US)、Roche (Switzerland)、Abbott (US)
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Sepsis Diagnostic Market
The global Sepsis Diagnostic market size is projected to reach US$ 371.7 million by 2026, from US$ 352.1 million in 2020, at a CAGR of 5.2%% during 2021-2026.

Global Sepsis Diagnostic Scope and Market Size
Sepsis Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sepsis Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bruker (US)
CytoSorbents (US)
EKF (US)
T2 Biosystems (US)
Luminex (US)
Thermo Fisher Scientific (US)
bioMerieux (France)
Danaher (US)
Becton, Dickinson and Company (US)
Roche (Switzerland)
Abbott (US)

Market segment by Type, the product can be split into
Laboratory Tests
Point-of-care Tests
Market segment by Application, split into
Hospitals
Pathology & Reference Laboratories

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sepsis Diagnostic Revenue
1.4 Market by Type
1.4.1 Global Sepsis Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Laboratory Tests
1.4.3 Point-of-care Tests
1.5 Market by Application
1.5.1 Global Sepsis Diagnostic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Pathology & Reference Laboratories
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Sepsis Diagnostic Market Perspective (2015-2026)
2.2 Global Sepsis Diagnostic Growth Trends by Regions
2.2.1 Sepsis Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sepsis Diagnostic Historic Market Share by Regions (2015-2020)
2.2.3 Sepsis Diagnostic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sepsis Diagnostic Market Growth Strategy
2.3.6 Primary Interviews with Key Sepsis Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Sepsis Diagnostic Players by Market Size
3.1.1 Global Top Sepsis Diagnostic Players by Revenue (2015-2020)
3.1.2 Global Sepsis Diagnostic Revenue Market Share by Players (2015-2020)
3.1.3 Global Sepsis Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sepsis Diagnostic Market Concentration Ratio
3.2.1 Global Sepsis Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sepsis Diagnostic Revenue in 2019
3.3 Sepsis Diagnostic Key Players Head office and Area Served
3.4 Key Players Sepsis Diagnostic Product Solution and Service
3.5 Date of Enter into Sepsis Diagnostic Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Sepsis Diagnostic Historic Market Size by Type (2015-2020)
4.2 Global Sepsis Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Sepsis Diagnostic Market Size by Application (2015-2020)
5.2 Global Sepsis Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Sepsis Diagnostic Market Size (2015-2020)
6.2 Sepsis Diagnostic Key Players in North America (2019-2020)
6.3 North America Sepsis Diagnostic Market Size by Type (2015-2020)
6.4 North America Sepsis Diagnostic Market Size by Application (2015-2020)

7 Europe
7.1 Europe Sepsis Diagnostic Market Size (2015-2020)
7.2 Sepsis Diagnostic Key Players in Europe (2019-2020)
7.3 Europe Sepsis Diagnostic Market Size by Type (2015-2020)
7.4 Europe Sepsis Diagnostic Market Size by Application (2015-2020)

8 China
8.1 China Sepsis Diagnostic Market Size (2015-2020)
8.2 Sepsis Diagnostic Key Players in China (2019-2020)
8.3 China Sepsis Diagnostic Market Size by Type (2015-2020)
8.4 China Sepsis Diagnostic Market Size by Application (2015-2020)

9 Japan
9.1 Japan Sepsis Diagnostic Market Size (2015-2020)
9.2 Sepsis Diagnostic Key Players in Japan (2019-2020)
9.3 Japan Sepsis Diagnostic Market Size by Type (2015-2020)
9.4 Japan Sepsis Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Sepsis Diagnostic Market Size (2015-2020)
10.2 Sepsis Diagnostic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sepsis Diagnostic Market Size by Type (2015-2020)
10.4 Southeast Asia Sepsis Diagnostic Market Size by Application (2015-2020)

11 India
11.1 India Sepsis Diagnostic Market Size (2015-2020)
11.2 Sepsis Diagnostic Key Players in India (2019-2020)
11.3 India Sepsis Diagnostic Market Size by Type (2015-2020)
11.4 India Sepsis Diagnostic Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Sepsis Diagnostic Market Size (2015-2020)
12.2 Sepsis Diagnostic Key Players in Central & South America (2019-2020)
12.3 Central & South America Sepsis Diagnostic Market Size by Type (2015-2020)
12.4 Central & South America Sepsis Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bruker (US)
13.1.1 Bruker (US) Company Details
13.1.2 Bruker (US) Business Overview
13.1.3 Bruker (US) Sepsis Diagnostic Introduction
13.1.4 Bruker (US) Revenue in Sepsis Diagnostic Business (2015-2020))
13.1.5 Bruker (US) Recent Development
13.2 CytoSorbents (US)
13.2.1 CytoSorbents (US) Company Details
13.2.2 CytoSorbents (US) Business Overview
13.2.3 CytoSorbents (US) Sepsis Diagnostic Introduction
13.2.4 CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2015-2020)
13.2.5 CytoSorbents (US) Recent Development
13.3 EKF (US)
13.3.1 EKF (US) Company Details
13.3.2 EKF (US) Business Overview
13.3.3 EKF (US) Sepsis Diagnostic Introduction
13.3.4 EKF (US) Revenue in Sepsis Diagnostic Business (2015-2020)
13.3.5 EKF (US) Recent Development
13.4 T2 Biosystems (US)
13.4.1 T2 Biosystems (US) Company Details
13.4.2 T2 Biosystems (US) Business Overview
13.4.3 T2 Biosystems (US) Sepsis Diagnostic Introduction
13.4.4 T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2015-2020)
13.4.5 T2 Biosystems (US) Recent Development
13.5 Luminex (US)
13.5.1 Luminex (US) Company Details
13.5.2 Luminex (US) Business Overview
13.5.3 Luminex (US) Sepsis Diagnostic Introduction
13.5.4 Luminex (US) Revenue in Sepsis Diagnostic Business (2015-2020)
13.5.5 Luminex (US) Recent Development
13.6 Thermo Fisher Scientific (US)
13.6.1 Thermo Fisher Scientific (US) Company Details
13.6.2 Thermo Fisher Scientific (US) Business Overview
13.6.3 Thermo Fisher Scientific (US) Sepsis Diagnostic Introduction
13.6.4 Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2015-2020)
13.6.5 Thermo Fisher Scientific (US) Recent Development
13.7 bioMerieux (France)
13.7.1 bioMerieux (France) Company Details
13.7.2 bioMerieux (France) Business Overview
13.7.3 bioMerieux (France) Sepsis Diagnostic Introduction
13.7.4 bioMerieux (France) Revenue in Sepsis Diagnostic Business (2015-2020)
13.7.5 bioMerieux (France) Recent Development
13.8 Danaher (US)
13.8.1 Danaher (US) Company Details
13.8.2 Danaher (US) Business Overview
13.8.3 Danaher (US) Sepsis Diagnostic Introduction
13.8.4 Danaher (US) Revenue in Sepsis Diagnostic Business (2015-2020)
13.8.5 Danaher (US) Recent Development
13.9 Becton, Dickinson and Company (US)
13.9.1 Becton, Dickinson and Company (US) Company Details
13.9.2 Becton, Dickinson and Company (US) Business Overview
13.9.3 Becton, Dickinson and Company (US) Sepsis Diagnostic Introduction
13.9.4 Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2015-2020)
13.9.5 Becton, Dickinson and Company (US) Recent Development
13.10 Roche (Switzerland)
13.10.1 Roche (Switzerland) Company Details
13.10.2 Roche (Switzerland) Business Overview
13.10.3 Roche (Switzerland) Sepsis Diagnostic Introduction
13.10.4 Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2015-2020)
13.10.5 Roche (Switzerland) Recent Development
13.11 Abbott (US)
10.11.1 Abbott (US) Company Details
10.11.2 Abbott (US) Business Overview
10.11.3 Abbott (US) Sepsis Diagnostic Introduction
10.11.4 Abbott (US) Revenue in Sepsis Diagnostic Business (2015-2020)
10.11.5 Abbott (US) Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Sepsis Diagnostic Key Market Segments
Table 2. Key Players Covered: Ranking by Sepsis Diagnostic Revenue
Table 3. Ranking of Global Top Sepsis Diagnostic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sepsis Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Laboratory Tests
Table 6. Key Players of Point-of-care Tests
Table 7. Global Sepsis Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Sepsis Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Sepsis Diagnostic Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Sepsis Diagnostic Market Share by Regions (2015-2020)
Table 11. Global Sepsis Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Sepsis Diagnostic Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Sepsis Diagnostic Market Growth Strategy
Table 17. Main Points Interviewed from Key Sepsis Diagnostic Players
Table 18. Global Sepsis Diagnostic Revenue by Players (2015-2020) (Million US$)
Table 19. Global Sepsis Diagnostic Market Share by Players (2015-2020)
Table 20. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Diagnostic as of 2019)
Table 21. Global Sepsis Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sepsis Diagnostic Product Solution and Service
Table 24. Date of Enter into Sepsis Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 27. Global Sepsis Diagnostic Market Size Share by Type (2015-2020)
Table 28. Global Sepsis Diagnostic Revenue Market Share by Type (2021-2026)
Table 29. Global Sepsis Diagnostic Market Size Share by Application (2015-2020)
Table 30. Global Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 31. Global Sepsis Diagnostic Market Size Share by Application (2021-2026)
Table 32. North America Key Players Sepsis Diagnostic Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Sepsis Diagnostic Market Share (2019-2020)
Table 34. North America Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 35. North America Sepsis Diagnostic Market Share by Type (2015-2020)
Table 36. North America Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 37. North America Sepsis Diagnostic Market Share by Application (2015-2020)
Table 38. Europe Key Players Sepsis Diagnostic Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Sepsis Diagnostic Market Share (2019-2020)
Table 40. Europe Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Sepsis Diagnostic Market Share by Type (2015-2020)
Table 42. Europe Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Sepsis Diagnostic Market Share by Application (2015-2020)
Table 44. China Key Players Sepsis Diagnostic Revenue (2019-2020) (Million US$)
Table 45. China Key Players Sepsis Diagnostic Market Share (2019-2020)
Table 46. China Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 47. China Sepsis Diagnostic Market Share by Type (2015-2020)
Table 48. China Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 49. China Sepsis Diagnostic Market Share by Application (2015-2020)
Table 50. Japan Key Players Sepsis Diagnostic Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Sepsis Diagnostic Market Share (2019-2020)
Table 52. Japan Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Sepsis Diagnostic Market Share by Type (2015-2020)
Table 54. Japan Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Sepsis Diagnostic Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Sepsis Diagnostic Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Sepsis Diagnostic Market Share (2019-2020)
Table 58. Southeast Asia Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Sepsis Diagnostic Market Share by Type (2015-2020)
Table 60. Southeast Asia Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Sepsis Diagnostic Market Share by Application (2015-2020)
Table 62. India Key Players Sepsis Diagnostic Revenue (2019-2020) (Million US$)
Table 63. India Key Players Sepsis Diagnostic Market Share (2019-2020)
Table 64. India Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 65. India Sepsis Diagnostic Market Share by Type (2015-2020)
Table 66. India Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 67. India Sepsis Diagnostic Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Sepsis Diagnostic Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Sepsis Diagnostic Market Share (2019-2020)
Table 70. Central & South America Sepsis Diagnostic Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Sepsis Diagnostic Market Share by Type (2015-2020)
Table 72. Central & South America Sepsis Diagnostic Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Sepsis Diagnostic Market Share by Application (2015-2020)
Table 74. Bruker (US) Company Details
Table 75. Bruker (US) Business Overview
Table 76. Bruker (US) Product
Table 77. Bruker (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 78. Bruker (US) Recent Development
Table 79. CytoSorbents (US) Company Details
Table 80. CytoSorbents (US) Business Overview
Table 81. CytoSorbents (US) Product
Table 82. CytoSorbents (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 83. CytoSorbents (US) Recent Development
Table 84. EKF (US) Company Details
Table 85. EKF (US) Business Overview
Table 86. EKF (US) Product
Table 87. EKF (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 88. EKF (US) Recent Development
Table 89. T2 Biosystems (US) Company Details
Table 90. T2 Biosystems (US) Business Overview
Table 91. T2 Biosystems (US) Product
Table 92. T2 Biosystems (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 93. T2 Biosystems (US) Recent Development
Table 94. Luminex (US) Company Details
Table 95. Luminex (US) Business Overview
Table 96. Luminex (US) Product
Table 97. Luminex (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 98. Luminex (US) Recent Development
Table 99. Thermo Fisher Scientific (US) Company Details
Table 100. Thermo Fisher Scientific (US) Business Overview
Table 101. Thermo Fisher Scientific (US) Product
Table 102. Thermo Fisher Scientific (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 103. Thermo Fisher Scientific (US) Recent Development
Table 104. bioMerieux (France) Company Details
Table 105. bioMerieux (France) Business Overview
Table 106. bioMerieux (France) Product
Table 107. bioMerieux (France) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 108. bioMerieux (France) Recent Development
Table 109. Danaher (US) Business Overview
Table 110. Danaher (US) Product
Table 111. Danaher (US) Company Details
Table 112. Danaher (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 113. Danaher (US) Recent Development
Table 114. Becton, Dickinson and Company (US) Company Details
Table 115. Becton, Dickinson and Company (US) Business Overview
Table 116. Becton, Dickinson and Company (US) Product
Table 117. Becton, Dickinson and Company (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 118. Becton, Dickinson and Company (US) Recent Development
Table 119. Roche (Switzerland) Company Details
Table 120. Roche (Switzerland) Business Overview
Table 121. Roche (Switzerland) Product
Table 122. Roche (Switzerland) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 123. Roche (Switzerland) Recent Development
Table 124. Abbott (US) Company Details
Table 125. Abbott (US) Business Overview
Table 126. Abbott (US) Product
Table 127. Abbott (US) Revenue in Sepsis Diagnostic Business (2015-2020) (Million US$)
Table 128. Abbott (US) Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sepsis Diagnostic Market Share by Type: 2020 VS 2026
Figure 2. Laboratory Tests Features
Figure 3. Point-of-care Tests Features
Figure 4. Global Sepsis Diagnostic Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Pathology & Reference Laboratories Case Studies
Figure 7. Sepsis Diagnostic Report Years Considered
Figure 8. Global Sepsis Diagnostic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Sepsis Diagnostic Market Share by Regions: 2020 VS 2026
Figure 10. Global Sepsis Diagnostic Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Sepsis Diagnostic Market Share by Players in 2019
Figure 13. Global Top Sepsis Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sepsis Diagnostic as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Sepsis Diagnostic Revenue in 2019
Figure 15. North America Sepsis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Sepsis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Sepsis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Sepsis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Sepsis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Sepsis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Sepsis Diagnostic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed